Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

DTAB Sub-Panel to Reassess 29 'Irrational' FDCs Flagged by Kokate Committee: Report

Susmita Roy17 Feb 2026 11:00 PM IST

New Delhi: In a major move to strengthen drug safety and rational prescribing practices, regulators have initiated a renewed examination of 29...

Alkem Binding Offer to Acquire Stake in Occlutech

Alkem Arm Makes Binding Offer to Acquire 51-55% Stake in Swiss Medtech Firm Occlutech

Susmita Roy16 Feb 2026 6:30 PM IST

New Delhi: Alkem Laboratories Limited announced that its wholly owned subsidiary, Alkem Medtech Private Limited, has made a binding offer dated...

Aurobindo Subsidiary Eugia Launches Generic Pomalyst Capsules in US

Aurobindo Arm Acrotech Secures USFDA Nod for Atopic Dermatitis Drug ADQUEY

Susmita Roy16 Feb 2026 5:00 PM IST

New Delhi: Aurobindo Pharma Limited announced that its wholly owned step-down subsidiary, Acrotech Biopharma, has received approval from the U.S. Food...

Dadachanji Group Enters Medical Devices Space, Launches KAIRISH Innotech

DoP Issues Draft Revised List of 354 Medical Devices Exempt from Global Procurement, Invites Stakeholder Input

Susmita Roy15 Feb 2026 2:52 PM IST

New Delhi: The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, Government of India, has issued a public notice inviting...

All Cancer Drugs Regulated Under DPCO, 131 Formulations Price-Capped: Govt

Susmita Roy15 Feb 2026 2:00 PM IST

New Delhi: The Government has clarified that all oncology medicines are covered under the Drugs (Prices Control) Order, 2013 (DPCO, 2013) either...

Shilpa Medicare Partners NXI Therapeutics for Autoimmune Therapy Development, Manufacturing

Susmita Roy15 Feb 2026 1:45 PM IST

New Delhi: Shilpa Medicare has announced the strategic partnership for a long-term development and commercial manufacturing agreement with NXI...

Pharma Companies Told to Cut Prices of 17 Duty Exempt Cancer Drugs

Susmita Roy13 Feb 2026 8:41 PM IST

New Delhi: In a follow-up to the customs duty relief on essential medicines, the National Pharmaceutical Pricing Authority (NPPA) has directed...

USV Acquires 79% Stake in Wellbeing Nutrition, Values D2C Startup at Rs 1,583 Cr

Susmita Roy13 Feb 2026 1:44 PM IST

New Delhi: USV Pvt Ltd, widely recognised for its leading brands in diabetes and cardiovascular therapy, has acquired a 79 percent stake in...

Lupin Appoints Dr Kushkumar Thakare as Manager, Medical Affairs for India Region

Susmita Roy13 Feb 2026 1:21 PM IST

New Delhi: Lupin has announced the appointment of Dr Kushkumar Thakare as Manager, Medical Affairs, India Region Formulations, reinforcing the...

Indian Pharma Market Kicks Off 2026 With 10% Growth in January: PharmaTrac

Susmita Roy12 Feb 2026 11:54 PM IST

New Delhi: The Indian Pharmaceutical Market (IPM) started calendar year 2026 with a robust uptick, delivering 10.21% month-on-month value growth and...

After Auditing 90% of Cough Syrup Units, CDSCO Tightens GMP Net, 850 CAPA Notices Served

Over 200 Human and Veterinary Drugs Banned Since 2023, Parliament Told

Susmita Roy12 Feb 2026 7:30 PM IST

New Delhi: The central government intensified regulatory action against unsafe medicines, banning 172 drugs meant for human use and 39 veterinary...

SC Refuses Interim Relief to Piramal Pharma in Dahej Unit Closure

Susmita Roy11 Feb 2026 9:00 PM IST

New Delhi: The Supreme Court on Monday declined to grant interim relief to Piramal Pharma in its challenge to the closure of its Dahej manufacturing...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok